Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00248560
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2005-11-03
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Persistent Recurrent or Metastatic Head and Neck Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Barbara Ann Karmanos Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| recurrent squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| recurrent squamous cell carcinoma of the larynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| recurrent squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| metastatic squamous neck cancer with occult primary squamous cell carcinoma | View |
| recurrent metastatic squamous neck cancer with occult primary | View |
| recurrent squamous cell carcinoma of the nasopharynx | View |
| stage IV squamous cell carcinoma of the nasopharynx | View |
| recurrent squamous cell carcinoma of the oropharynx | View |
| stage IV squamous cell carcinoma of the oropharynx | View |
| recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity | View |